Activation-induced cytidine deaminase and aberrant germinal center selection in the development of humoral autoimmunities

American Journal of Pathology

Volumn 178, Issue 2, 2011, Pages 462-471

  Zaheen, Ahmad ^a   Martin, Alberto ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CYTIDINE DEAMINASE; ENZYME; IMMUNOGLOBULIN;

ANTIBODY PRODUCTION; APOPTOSIS; AUTOIMMUNITY; B CELL LYMPHOMA; B LYMPHOCYTE; CELL CLONE; DNA MODIFICATION; GERMINAL CENTER; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOGLOBULIN GENE; IMMUNOREACTIVITY; LYMPHOID TISSUE; MOLECULAR CLONING; NONHUMAN; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 79951839241     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.09.044     Document Type: Review

References (100)

1. Goodnow CC: Multistep pathogenesis of autoimmune disease. Cell 2007, 130:25-35
2. Meffre E, Wardemann H: B-cell tolerance checkpoints in health and autoimmunity. Curr Opin Immunol 2008, 20:632-638
3. Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC: Predominant autoantibody production by early human B cell precursors. Science 2003, 301:1374-1377 (Pubitemid 37075812)
4. Ramiro A, San-Martin BR, McBride K, Jankovic M, Barreto V, Nussenzweig A, Nussenzweig MC: The role of activation-induced deaminase in antibody diversification and chromosome translocations. Adv Immunol 2007, 94:75-107 (Pubitemid 46856608)
5. Klein U, Dalla-Favera R: Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 2008, 8:22-33
6. Nacionales DC, Weinstein JS, Yan XJ, Albesiano E, Lee PY, Kelly-Scumpia KM, Lyons R, Satoh M, Chiorazzi N, Reeves WH: B cell proliferation, somatic hypermutation, class switch recombination, and autoantibody production in ectopic lymphoid tissue in murine lupus. J Immunol 2009, 182:4226-4236
7. Kim HJ, Berek C: B cells in rheumatoid arthritis. Arthritis Res 2000, 2:126-131
8. Zuckerman NS, Howard WA, Bismuth J, Gibson K, Edelman H, Berrih-Aknin S, Dunn-Walters D, Mehr R: Ectopic GC in the thymus of myasthenia gravis patients show characteristics of normal GC. Eur J Immunol 2010, 40:1150-1161
9. Stott DI, Hiepe F, Hummel M, Steinhauser G, Berek C: Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease: the salivary glands of patients with Sjögren's syndrome. J Clin Invest 1998, 102:938-946 (Pubitemid 28419239)
10. Lin RH, Mamula MJ, Hardin JA, Janeway CA Jr: Induction of autoreactive B cells allows priming of autoreactive T cells. J Exp Med 1991, 173:1433-1439
11. Takemura S, Klimiuk PA, Braun A, Goronzy JJ, Weyand CM: T cell activation in rheumatoid synovium is B cell dependent. J Immunol 2001, 167:4710-4718 (Pubitemid 32954353)
12. Shlomchik M, Mascelli M, Shan H, Radic MZ, Pisetsky D, Marshak-Rothstein A, Weigert M: Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med 1990, 171:265-292
13. Han S, Zheng B, Dal Porto J, Kelsoe G: In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl, IV: affinity-dependent, antigen-driven B cell apoptosis in germinal centers as a mechanism for maintaining self-tolerance. J Exp Med 1995, 182:1635-1644
14. Fanning LJ, Connor AM, Wu GE: Development of the immunoglobulin repertoire. Clin Immunol Immunopathol 1996, 79:1-14 (Pubitemid 26150326)
15. Neuberger MS: Antibody diversification by somatic mutation: from Burnet onwards. Immunol Cell Biol 2008, 86:124-132
16. Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, Catalan N, Forveille M, Dufourcq-Labelouse R, Gennery A, Tezcan I, Ersoy F, Kayserili H, Ugazio AG, Brousse N, Muramatsu M, Notarangelo LD, Kinoshita K, Honjo T, Fischer A, Durandy A: Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 2000, 102:565-575
17. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T: Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000, 102:553-563
18. Petersen-Mahrt SK, Harris RS, Neuberger MS: AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 2002, 418:99-104
19. Di Noia J, Neuberger MS: Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase. Nature 2002, 419:43-48 (Pubitemid 34987864)
20. Bransteitter R, Pham P, Scharff MD, Goodman MF: Activation-induced cytidine deaminase deaminates deoxycytidine on singlestranded DNA but requires the action of RNase. Proc Natl Acad Sci U S A 2003, 100:4102-4107 (Pubitemid 36418164)
21. Martin A, Bardwell PD, Woo CJ, Fan M, Shulman MJ, Scharff MD: Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas. Nature 2002, 415:802-806 (Pubitemid 34150503)
22. Aoufouchi S, Faili A, Zober C, D'Orlando O, Weller S, Weill JC, Reynaud CA: Proteasomal degradation restricts the nuclear lifespan of AID. J Exp Med 2008, 205:1357-1368 (Pubitemid 351831492)
23. Basu U, Wang Y, Alt FW: Evolution of phosphorylation-dependent regulation of activation-induced cytidine deaminase. Mol Cell 2008, 32:285-291
24. Xu Z, Pone EJ, Al-Qahtani A, Park SR, Zan H, Casali P: Regulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombination. Crit Rev Immunol 2007, 27:367-397
25. Muto T, Okazaki IM, Yamada S, Tanaka Y, Kinoshita K, Muramatsu M, Nagaoka H, Honjo T: Negative regulation of activation-induced cytidine deaminase in B cells. Proc Natl Acad Sci U S A 2006, 103:2752-2757
26. Wolniak KL, Shinall SM, Waldschmidt TJ: The germinal center response. Crit Rev Immunol 2004, 24:39-65 (Pubitemid 39655011)
27. Allen CD, Okada T, Cyster JG: Germinal-center organization and cellular dynamics. Immunity 2007, 27:190-202 (Pubitemid 47284923)
28. McHeyzer-Williams LJ, McHeyzer-Williams MG: Antigen-specific memory B cell development. Annu Rev Immunol 2005, 23:487-513 (Pubitemid 40563178)
29. Manser T: Textbook germinal centers? J Immunol 2004, 172:3369-3375
30. Jacob J, Kassir R, Kelsoe G: In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl, I: the architecture and dynamics of responding cell populations. J Exp Med 1991, 173:1165-1175
31. Garside P, Ingulli E, Merica RR, Johnson JG, Noelle RJ, Jenkins MK: Visualization of specific B and T lymphocyte interactions in the lymph node. Science 1998, 281:96-99 (Pubitemid 28354051)
32. Clark LB, Foy TM, Noelle RJ: CD40 and its ligand. Adv Immunol 1996, 63:43-78 (Pubitemid 26296138)
33. Kawabe T, Naka T, Yoshida K, Tanaka T, Fujiwara H, Suematsu S, Yoshida N, Kishimoto T, Kikutani H: The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1994, 1:167-178
34. Jacob J, Kelsoe G: In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl, II: a common clonal origin for periarteriolar lymphoid sheath-associated foci and germinal centers. J Exp Med 1992, 176:679-687
35. Allen CD, Ansel KM, Low C, Lesley R, Tamamura H, Fujii N, Cyster JG: Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat Immunol 2004, 5:943-952 (Pubitemid 39276239)
36. Liu YJ, Zhang J, Lane PJ, Chan EY, MacLennan IC: Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur J Immunol 1991, 21:2951-2962
37. Cozine CL, Wolniak KL, Waldschmidt TJ: The primary germinal center response in mice. Curr Opin Immunol 2005, 17:298-302 (Pubitemid 40692665)
38. Tarlinton DM, Smith KG: Apoptosis and the B cell response to antigen. Int Rev Immunol 1997, 15:53-71 (Pubitemid 27237683)
39. Allen CD, Cyster JG: Follicular dendritic cell networks of primary follicles and germinal centers: phenotype and function. Semin Immunol 2008, 20:14-25
40. Park CS, Choi YS: How do follicular dendritic cells interact intimately with B cells in the germinal centre? Immunology 2005, 114:2-10
41. Walker LS, Gulbranson-Judge A, Flynn S, Brocker T, Lane PJ: Costimulation and selection for T-cell help for germinal centres: the role of CD28 and OX40. Immunol Today 2000, 21:333-337 (Pubitemid 30428304)
42. Cornall RJ, Goodnow CC, Cyster JG: The regulation of self-reactive B cells. Curr Opin Immunol 1995, 7:804-811 (Pubitemid 26038521)
43. Pulendran B, Smith KG, Nossal GJ: Soluble antigen can impede affinity maturation and the germinal center reaction but enhance extrafollicular immunoglobulin production. J Immunol 1995, 155:1141-1150
44. Shokat KM, Goodnow CC: Antigen-induced B-cell death and elimination during germinal-centre immune responses. Nature 1995, 375:334-338
45. Allen CD, Okada T, Tang HL, Cyster JG: Imaging of germinal center selection events during affinity maturation. Science 2007, 315:528-531 (Pubitemid 46175759)
46. Schwickert TA, Lindquist RL, Shakhar G, Livshits G, Skokos D, Kosco-Vilbois MH, Dustin ML, Nussenzweig MC: In vivo imaging of germinal centres reveals a dynamic open structure. Nature 2007, 446:83-87
47. Diamond B, Katz JB, Paul E, Aranow C, Lustgarten D, Scharff MD: The role of somatic mutation in the pathogenic anti-DNA response. Annu Rev Immunol 1992, 10:731-757
48. Hsu HC, Wu Y, Yang P, Wu Q, Job G, Chen J, Wang J, Accavitti-Loper MA, Grizzle WE, Carter RH, Mountz JD: Overexpression of activation-induced cytidine deaminase in B cells is associated with production of highly pathogenic autoantibodies. J Immunol 2007, 178:5357-5365 (Pubitemid 46595322)
49. Xu X, Hsu HC, Chen J, Grizzle WE, Chatham WW, Stockard CR, Wu Q, Yang PA, Holers VM, Mountz JD: Increased expression of activation-induced cytidine deaminase is associated with anti-CCP and rheumatoid factor in rheumatoid arthritis. Scand J Immunol 2009, 70:309-316
50. Jiang C, Foley J, Clayton N, Kissling G, Jokinen M, Herbert R, Diaz M: Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice. J Immunol 2007, 178:7422-7431 (Pubitemid 46847470)
51. Jiang C, Zhao ML, Diaz M: Activation-induced deaminase heterozygous MRL/lpr mice are delayed in the production of high-affinity pathogenic antibodies and in the development of lupus nephritis. Immunology 2009, 126:102-113
52. Takizawa M, Tolarova H, Li Z, Dubois W, Lim S, Callen E, Franco S, Mosaico M, Feigenbaum L, Alt FW, Nussenzweig A, Potter M, Casellas R: AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development. J Exp Med 2008, 205:1949-1957
53. Sernandez IV, de Yebenes VG, Dorsett Y, Ramiro AR: Haploinsufficiency of activation-induced deaminase for antibody diversification and chromosome translocations both in vitro and in vivo. PLoS One 2008, 3:e3927
54. Zan H, Zhang J, Ardeshna S, Xu Z, Park SR, Casali P: Lupus-prone MRL/faslpr/lpr mice display increased AID expression and extensive DNA lesions, comprising deletions and insertions, in the immunoglobulin locus: concurrent upregulation of somatic hypermutation and class switch DNA recombination. Autoimmunity 2009, 42:89-103
55. Quartier P, Bustamante J, Sanal O, Plebani A, Debre M, Deville A, Litzman J, Levy J, Fermand JP, Lane P, Horneff G, Aksu G, Yalcin I, Davies G, Tezcan I, Ersoy F, Catalan N, Imai K, Fischer A, Durandy A: Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to activation-induced cytidine deaminase deficiency. Clin Immunol 2004, 110:22-29 (Pubitemid 38177417)
56. Jesus AA, Duarte AJ, Oliveira JB: Autoimmunity in hyper-IgM syndrome. J Clin Immunol 2008, 28(Suppl 1):S62-S66
57. Hase K, Takahashi D, Ebisawa M, Kawano S, Itoh K, Ohno H: Activation-induced cytidine deaminase deficiency causes organ-specific autoimmune disease. PLoS ONE 2008, 3:e3033
58. Chen L, Guo L, Tian J, Zheng B, Han S: Deficiency in activation-induced cytidine deaminase promotes systemic autoimmunity in lpr mice on a C57BL/6 background. Clin Exp Immunol 2010, 159:169-175
59. Zaheen A, Boulianne B, Parsa JY, Ramachandran S, Gommerman JL, Martin A: AID constrains germinal center size by rendering B cells susceptible to apoptosis. Blood 2009, 114:547-554
60. Bolland S, Ravetch JV: Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 2000, 13:277-285
61. Pao LI, Lam KP, Henderson JM, Kutok JL, Alimzhanov M, Nitschke L, Thomas ML, Neel BG, Rajewsky K: B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity. Immunity 2007, 27:35-48 (Pubitemid 47089020)
62. Miyamoto A, Nakayama K, Imaki H, Hirose S, Jiang Y, Abe M, Tsukiyama T, Nagahama H, Ohno S, Hatakeyama S, Nakayama KI: Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta. Nature 2002, 416:865-869 (Pubitemid 34453744)
63. Rahman ZS, Niu H, Perry D, Wakeland E, Manser T, Morel L: Expression of the autoimmune Fcgr2b NZW allele fails to be upregulated in germinal center B cells and is associated with increased IgG production. Genes Immun 2007, 8:604-612 (Pubitemid 350011692)
64. Rahman ZS, Alabyev B, Manser T: FcgammaRIIB regulates autoreactive primary antibody-forming cell, but not germinal center B cell, activity. J Immunol 2007, 178:897-907 (Pubitemid 46095162)
65. Bombardieri M, Barone F, Humby F, Kelly S, McGurk M, Morgan P, Challacombe S, De Vita S, Valesini G, Spencer J, Pitzalis C: Activation- induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjögren's syndrome. J Immunol 2007, 179:4929-4938
66. Tsubata T: B cell abnormality and autoimmune disorders. Autoimmunity 2005, 38:331-337
67. Kozono Y, Kotzin BL, Holers VM: Resting B cells from New Zealand Black mice demonstrate a defect in apoptosis induction following surface IgM ligation. J Immunol 1996, 156:4498-4503 (Pubitemid 26165853)
68. Sims GP, Shiono H, Willcox N, Stott DI: Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis. J Immunol 2001, 167:1935-1944 (Pubitemid 32747498)
69. Luzina IG, Atamas SP, Storrer CE, daSilva LC, Kelsoe G, Papadimitriou JC, Handwerger BS: Spontaneous formation of germinal centers in autoimmune mice. J Leukoc Biol 2001, 70:578-584 (Pubitemid 32954768)
70. Victoratos P, Kollias G: Induction of autoantibody-mediated spontaneous arthritis critically depends on follicular dendritic cells. Immunity 2009, 30:130-142
71. Vuyyuru R, Mohan C, Manser T, Rahman ZS: The lupus susceptibility locus Sle1 breaches peripheral B cell tolerance at the antibody-forming cell and germinal center checkpoints. J Immunol 2009, 183:5716-5727
72. Takahashi Y, Ohta H, Takemori T: Fas is required for clonal selection in germinal centers and the subsequent establishment of the memory B cell repertoire. Immunity 2001, 14:181-192 (Pubitemid 32206520)
73. Hoch S, Boyd M, Malone B, Gonye G, Schwaber J, Schwaber J: Fas-mediated apoptosis eliminates B cells that acquire self-reactivity during the germinal center response to NP. Cell Immunol 2000, 203:103-110
74. Moulian N, Berrih-Aknin S: Fas/APO-1/CD95 in health and autoimmune disease: thymic and peripheral aspects. Semin Immunol 1998, 10:449-456 (Pubitemid 28564374)
75. Hao Z, Duncan GS, Seagal J, Su YW, Hong C, Haight J, Chen NJ, Elia A, Wakeham A, Li WY, Liepa J, Wood GA, Casola S, Rajewsky K, Mak TW: Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis. Immunity 2008, 29:615-627
76. Hande S, Notidis E, Manser T: Bcl-2 obstructs negative selection of autoreactive, hypermutated antibody V regions during memory B cell development. Immunity 1998, 8:189-198 (Pubitemid 28123746)
77. Notidis E, Hande S, Manser T: Enforced expression of Bcl-2 selectively perturbs negative selection of dual reactive antibodies. Dev Immunol 2001, 8:223-234 (Pubitemid 34019535)
78. Strasser A, Whittingham S, Vaux DL, Bath ML, Adams JM, Cory S, Harris AW: Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci U S A 1991, 88:8661-8665 (Pubitemid 21915417)
79. Fischer SF, Bouillet P, O'Donnell K, Light A, Tarlinton DM, Strasser A: Proapoptotic BH3-only protein Bim is essential for developmentally programmed death of germinal center-derived memory B cells and antibody-forming cells. Blood 2007, 110:3978-3984
80. Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, Kontgen F, Adams JM, Strasser A: Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 1999, 286:1735-1738 (Pubitemid 129515880)
81. O'Keefe TL, Williams GT, Batista FD, Neuberger MS: Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J Exp Med 1999, 189:1307-1313 (Pubitemid 29198268)
82. Nishimura H, Nose M, Hiai H, Minato N, Honjo T: Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999, 11:141-151 (Pubitemid 29428807)
83. Inaoki M, Sato S, Weintraub BC, Goodnow CC, Tedder TF: CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J Exp Med 1997, 186:1923-1931 (Pubitemid 27524601)
84. Mackay F, Woodcock SA, Lawton P, Ambrose C, Baetscher M, Schneider P, Tschopp J, Browning JL: Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 1999, 190:1697-1710 (Pubitemid 30002351)
85. Gutierrez T, Halcomb KE, Coughran AJ, Li QZ, Satterthwaite AB: Separate checkpoints regulate splenic plasma cell accumulation and IgG autoantibody production in Lyn-deficient mice. Eur J Immunol 2010, 40:1897-1905
86. Zimmermann KC, Bonzon C, Green DR: The machinery of programmed cell death. Pharmacol Ther 2001, 92:57-70 (Pubitemid 34032022)
87. Movassagh M, Foo RS: Simplified apoptotic cascades. Heart Fail Rev 2008, 13:111-119
88. Schultz DR, Harrington WJ Jr: Apoptosis: programmed cell death at a molecular level, Semin Arthritis Rheum 2003, 32:345-369 (Pubitemid 36759363)
89. Strasser A, Bouillet P: The control of apoptosis in lymphocyte selection. Immunol Rev 2003, 193:82-92 (Pubitemid 36688042)
90. Sobel ES: Cellular interactions in the lpr and gld models of systemic autoimmunity. Adv Dent Res 1996, 10:76-80
91. Vaishnaw AK, Toubi E, Ohsako S, Drappa J, Buys S, Estrada J, Sitarz A, Zemel L, Chu JL, Elkon KB: The spectrum of apoptotic defects and clinical manifestations, including systemic lupus erythematosus, in humans with CD95 (Fas/APO-1) mutations. Arthritis Rheum 1999, 42:1833-1842 (Pubitemid 30257747)
92. Smith KG, Nossal GJ, Tarlinton DM: FAS is highly expressed in the germinal center but is not required for regulation of the B-cell response to antigen. Proc Natl Acad Sci U S A 1995, 92:11628-11632 (Pubitemid 26014166)
93. Alabyev B, Vuyyuru R, Manser T: Influence of Fas on the regulation of the response of an anti-nuclear antigen B cell clonotype to foreign antigen. Int Immunol 2008, 20:1279-1287
94. Smith KG, Light A, O'Reilly LA, Ang SM, Strasser A, Tarlinton D: bcl-2 transgene expression inhibits apoptosis in the germinal center and reveals differences in the selection of memory B cells and bone marrow antibody-forming cells. J Exp Med 2000, 191:475-484
95. Takahashi Y, Cerasoli DM, Dal Porto JM, Shimoda M, Freund R, Fang W, Telander DG, Malvey EN, Mueller DL, Behrens TW, Kelsoe G: Relaxed negative selection in germinal centers and impaired affinity maturation in bcl-xL transgenic mice. J Exp Med 1999, 190:399-410
96. Aït-Azzouzene D, Kono DH, Gonzalez-Quintial R, McHeyzer-Williams LJ, Lim M, Wickramarachchi D, Gerdes T, Gavin AL, Skog P, McHeyzer-Williams MG, Nemazee D, Theofilopoulos AN: Deletion of IgG-switched autoreactive B cells and defects in Fas(lpr) lupus mice. J Immunol 185:1015-1027
97. Edwards JC, Cambridge G: B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat Rev Immunol 2006, 6:394-403
98. Browning JL: B cells move to centre stage: novel opportunities for autoimmune disease treatment. Nat Rev Drug Discov 2006, 5:564-576
99. Mok MY: The immunological basis of B-cell therapy in systemic lupus erythematosus. Int J Rheum Dis 2010, 13:3-11
100. Blank M, Shoenfeld Y: B cell targeted therapy in autoimmunity. J Autoimmun 2007, 28:62-68 (Pubitemid 46680498)